Celiac Disease: Novel Oral Inhibitor May Block Intestinal Damage ...Middle East

A randomized, phase 2 trial explored the safety and efficacy of ZED1227, a transglutaminase inhibitor, after 6 weeks at three doses. Medscape Medical News

Hence then, the article about celiac disease novel oral inhibitor may block intestinal damage was published today ( Friday 02/07/2021 - 05:31 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Celiac Disease: Novel Oral Inhibitor May Block Intestinal Damage )

Also on site :

• Saudi Arabia to unify LPG gas cylinder prices nationwide from January 2026
• Two dozen killed in Ukrainian strike on Russian New Year’s celebration – governor
• Volunteer in Iran’s Revolutionary Guard reportedly killed during widening protests